Navigation Links
Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
Date:11/25/2008

icals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the co
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
2. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
3. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
4. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
5. Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
6. Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
8. King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
9. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
10. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
11. Keryx Biopharmaceuticals Receives Nasdaq Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... parents access to a website containing information about the ... cost-effective way of increasing its uptake, new University of ... vaccine via a website containing information helping parents make ... per vaccination to the NHS than informing them solely ... a leaflet providing information about the vaccine. In each ...
(Date:7/28/2014)... July 28, 2014 According to the Greek ... is a comprehensive fitness guide that teaches men how to ... , Vkool reveals in its review that inside the ... Ways to gain the maximum muscle fiber ... build muscle and avoid fat gain , Ways ...
(Date:7/28/2014)... July 28, 2014 CW4K was among ... Lady Michelle Obama and Partnership for a Healthier ... they join the group's DrinkUP effort, which ... more often. , The seven organizations added included ... Outdoor Products, S’well Bottle, Santa Clara Valley Water District ...
(Date:7/28/2014)... DC (PRWEB) July 28, 2014 As ... many are looking to private exchanges. “Private Exchange ... August 6 webinar from Atlantic Information Services, will provide ... private exchange strategies for the future. , Barbara Gniewek, ... PwC with extensive experience in the private exchange sector ...
(Date:7/28/2014)... According to the Heartburn No More PDF review recently ... help people get rid of acid reflux naturally. ... heartburn and acid reflux. In addition, inside this book, people ... factors for reflux disease. , Vkool informs in its ... symptoms of reflux disease naturally without medications. The book also ...
Breaking Medicine News(10 mins):Health News:Online information most cost-effective means of increasing MMR uptake, research finds 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 3Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3
... Improving communications skills and the use of a simple ... inappropriate prescriptions of antibiotics, a joint Cardiff University trial ... trial, published in the British Medical Journal , ... Medicine together with researchers from the Maastricht University Medical ...
... Tartrate Sublingual Tablet in Treating Middle-of-the-Night Awakening ... in the Treatment of Obsessive Compulsive DisorderRICHMOND, ... (Nasdaq: TSPT ), a specialty ... commercialization of proprietary products that address important ...
... laser-assisted liposuction offers patients better results and quicker ... liposuction systems currently on the market; Now available ... 21 Palomar Medical Technologies, Inc. (Nasdaq: ... of light-based systems for cosmetic treatments, announced today ...
... Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), ... the Joint Venture Agreement with its Chinese partners. , ... most recent trip to China having completed the negotiations and ... has also received an initial order of 120 Agro-Jet(R) for ...
... Efficacy Rates in Patients with Challenging Anatomy Consistent ... May 21 New data presented today at ... that Abbott,s market-leading XIENCE V(R) Everolimus Eluting Coronary ... (target lesion revascularization), stent thrombosis and major adverse ...
... sprees to boost emotional well-being in hard times , , ... worries, some women may actually overspend to try to cheer ... 700 women found that 79 percent said they,d go on ... 40 percent listed "depression" and 60 percent listed "feeling a ...
Cached Medicine News:Health News:Blood tests and better communication skills could cut over-prescribing of antibiotics 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 2Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 3Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 4Health News:MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 5Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 6Health News:Shop 'Til You Drop: You May Feel Better 2
(Date:7/27/2014)... 2014 /PRNewswire-iReach/ -- This is a professional ... Chinese Vardenafil (CAS 224785-90-4) industry. The report ... (CAS 224785-90-4) including its classification, application and ... and China,s top manufacturers of Vardenafil (CAS ... value, cost, gross margin and market share ...
(Date:7/25/2014)... 25, 2014  Depomed, Inc. (NASDAQ: DEPO ... fiscal year 2014 financial results after the market closes ... conference call beginning at 4:30 pm EDT, 1:30 pm PDT to ... call by dialing 877-317-6789 ( United States ... be available via a live webcast on the investor ...
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
Breaking Medicine Technology:Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 2Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 3Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 4Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... gamma imaging,(BSGI) is effective in the detection of cancers ... a study presented today at the annual meeting of,the ... "BSGI can identify the most ... Rachel F. Brem, M.D., professor of,radiology and director of ...
... Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing ... launched two tests to evaluate the response ... to a primary immunodeficiency disorder, chemotherapy drugs, or because ... a transplant. The company launched the two new assays, ...
Cached Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: